Renalytix Welcomes Julian Baines as Executive Chairman
Portfolio - People | Nov 05, 2024 | Business Cloud
Renalytix plc, a leading company in the MedTech sector specializing in artificial intelligence-enabled in vitro diagnostics for kidney disease management, has appointed Julian Baines as its new executive chairman. Baines, who previously served as the non-executive chairman at Renalytix from March 2018 to June 2020, returns with a mandate to help scale the commercialisation of the company's technology. His appointment follows an £11.8 million share placing, aimed at driving business growth. Previously, Baines has held leadership roles at EKF Diagnostics Holdings Plc and BBI Holdings plc. As Renalytix targets profitability within two years, it recently reported $2.3 million in revenue for the financial year ending June 2024 and a pre-tax loss of $44.9 million.
Sectors
- MedTech
- Artificial Intelligence
- Healthcare
Geography
- United Kingdom – Renalytix is a London-based company with operations and corporate activities connected to the UK.
- United States – The company also has a presence in New York, indicating its strategic interest in the U.S. market.
Industry
- MedTech – Renalytix operates in the MedTech industry, focusing particularly on AI-enabled diagnostics for kidney disease.
- Artificial Intelligence – The company employs artificial intelligence in its approach to in vitro diagnostics.
- Healthcare – Renalytix is involved in the healthcare sector through its diagnostics and disease management offerings.
Financials
- £11.8 million – Amount raised by Renalytix plc through a share placing for scaling commercialization.
- $2.3 million – Revenue generated by Renalytix plc for the financial year ended 30th June 2024.
- $44.9 million – Loss before tax reported by Renalytix plc for the financial year ended 30th June 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Renalytix plc | Target Company | Company | A MedTech company specializing in AI-enabled in vitro diagnostics for managing kidney disease. |
| Julian Baines | Executive Chairman | Person | Formerly non-executive chairman of Renalytix, Baines returns to lead the company with executive responsibilities. |
| Christopher Mills | Non-Executive Director | Person | Former executive chairman moving to a non-executive director role at Renalytix. |
| James McCullough | CEO | Person | Chief Executive Officer of Renalytix plc. |
| EKF Diagnostics Holdings Plc | Other Company | Company | Previous company where Julian Baines held CEO and executive chairman positions. |
| BBI Holdings plc | Other Company | Company | Former company where Julian Baines was CEO and led significant corporate events. |
| Verici Dx plc | Other Company | Company | Company where Julian Baines holds a non-exec chairman role. |